MIRA INFORM REPORT

 

 

Report Date :

03.07.2007

 

IDENTIFICATION DETAILS

 

Name :

COLORCON ASIA PRIVATE LIMITED

 

 

Registered Office :

Plot Nos M14 – M18, Verna Industrial Estate, Verna - 403722, Goa

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

22.04.1994

 

 

Com. Reg. No.:

24-3308

 

 

CIN No.:

[Company Identification No.]

U01122GA1994PTC003308

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRC04981E

 

 

PAN No.:

[Permanent Account No.]

AAACC2281Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Importing and Exporting of Food colours, lake dyes, colouring materials used in table coating, confectioneries, medicines, toiletries, process foods, insecticides, plastics, cosmetics and chemicals.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2500000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having satisfactory track records. Directors are reported as experienced and respectable businessmen. Trade relations are reported as fair. Business is active. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

Plot Nos M14 – M18, Verna Industrial Estate, Verna - 403722, Goa, India

Tel. No.:

91-832-2883434

Fax No.:

91-832-2883440

E-Mail :

info@colorcon.com

koza@colorcon.com

ksheth@colorcon.com

Website :

http://www.colorcon.com

 

 

DIRECTORS

 

Name :

Mr. Stephen Francis Stephen William Zenuh

Designation :

Director

Address :

51, Merchant Road, 03-05, Merchant Sequare, Singapore – 58283

Date of Birth/Age :

18.08.1951

Date of Appointment :

01.06.2002

 

 

Name :

Mr. Kamlesh Pratapray Oza

Designation :

Managing Director

Address :

Shivprasad, 97, Marine Drive, Marine Lines, Mumbai – 400002, Maharashtra, India

Date of Birth/Age :

19.08.1960

Date of Appointment :

22.04.1994

 

 

Name :

Mr. Cornels Woldemar Van Den Muyzenberg

Designation :

Director

Address :

51, Merchant Road, 06-05, Merchant Sequare, Singapore – 58283

Date of Birth/Age :

20.01.1964

Date of Appointment :

07.02.2007

 

 

KEY EXECUTIVES

 

Name :

Mr. Prashant Diwan

Designation :

Company Secretary

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Colorcon Limited

 

16,34,449

Micron Limited

 

1

Total

 

16,34,450

 

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Importing and Exporting of Food colours, lake dyes, colouring materials used in table coating, confectioneries, medicines, toiletries, process foods, insecticides, plastics, cosmetics and chemicals.

 

 

Products :

v      Cellulose Ether

v      Dry Dispersion

v      Excipients

 

 

GENERAL INFORMATION

 

Bankers :

Citi Bank NA

Bandra Kurla Complex, G-Block Bandra [East], Mumbai – 400051, Maharashtra, India

 

 

Facilities :

--

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S. R. Batliboi and Company

Chartered Accountants

Address :

6th Floor, Express Towers, Nariman Point, Mumbai – 400021, Maharashtra, India

 

 

Associates:

v      Colorcon Limited

v      Micron Limited

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1634450

Equity Shares

Rs. 10/- each

Rs. 16.345 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

1634450

Equity Shares

Rs. 10/- each

Rs. 16.345 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2006

31.03.2005

31.03.2004

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

16.345

16.345

16.344

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

614.572

442.640

400.272

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

630.917

458.985

416.616

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

45.948

TOTAL BORROWING

0.000

0.000

45.948

DEFERRED TAX LIABILITIES

20.467

14.996

14.662

 

 

 

 

TOTAL

651.384

473.981

477.226

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

228.614

230.181

209.528

Capital work-in-progress

5.991

3.000

11.072

 

 

 

 

INVESTMENT

0.000

0.000

0.490

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

127.841

95.811

70.926

 

Sundry Debtors

255.781

158.021

137.330

 

Cash & Bank Balances

193.275

115.948

94.428

 

Other Current Assets

2.607

0.457

0.289

 

Loans & Advances

42.988

36.616

109.080

Total Current Assets

622.492

406.853

412.053

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

99.388

72.869

58.774

 

Provisions

106.325

93.184

97.143

Total Current Liabilities

205.713

166.053

155.917

Net Current Assets

416.779

240.800

256.136

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

651.384

473.981

477.226

 


 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2006

 

31.03.2005

31.03.2004

Sales Turnover

982.000

N.A.

584.763

 

 

 

 

Profit/(Loss) Before Tax

341.851

NA

110.329

Provision for Taxation

63.876

NA

39.599

Profit/(Loss) After Tax

277.975

NA

70.730

 

 

 

 

Earnings in Foreign Currency :

 

 

 

 

Export Earnings

129.379

NA

8.183

Total Earnings

129.379

NA

8.183

 

 

 

 

Imports :

 

 

 

 

Raw Materials

0.000

NA

246.650

 

Capital Goods

0.000

NA

5.463

Total Imports

0.000

NA

252.113

 

 

 

 

Expenditures :

 

 

 

 

Travelling

NA

NA

3.205

 

Software Expenditure

NA

NA

3.330

 

Stores

NA

NA

0.266

 

Interest

NA

NA

1.577

 

Other Expenses

NA

NA

0.711

Total Expenditure

618.444

NA

9.089

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2006

31.03.2005

31.03.2004

PAT / Total Income

(%)

28.31

NA

12.10

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

34.81

NA

18.87

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

39.88

NA

17.75

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.54

NA

0.26

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.33

0.36

0.48

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

3.03

2.45

2.64

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

Name of the company

COLORCON ASIA PRIVATE LIMITED

Presented By

Mr. Kamlesh Oza

1) Date and description of instrument creating the change

Goods Security Agreement dated 21.06.2001 executed by  Colorcon Asia Private Limited in favour of Citi Bank

2) Amount secured by the charge/amount owing on the securities of charge

Total Fund based facilities for Rs. 24.000 Millions and Non Fund based facilities for Rs. 2.500 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of Stock, Book Debts forming part of its assets both present and future.

4) Gist of the terms and conditions and extent and operation of the charge.

In consideration of the lender having agreed to lend advance to the company. Fund based facilities under agreement and declaration by the company, inter alia as follow :

 

Covenant by the company to repay the facility  as [2]  above and pay interest and all other monies in the manner set out in the said agreement between the company and the lender and to comply with the terms and conditions of the said agreement.

 

The said movables hypothecated and property mortgaged, to the lender as and by way of first charge as security for and be charged with the repayment of the loan with all interest, liquidated, damages, premia on prepayment or on redemption, costs, charges, and other expenses payable by the company to the lender in respect thereof

Margin : 36 % on stock and 52 % on machinery

 

The companies to keep the said assets in marketable and good condition and also insured as provided therein

 

Power of entry, power to take charge and / or possession of seize, recover, receive appoint and sell, contract dispatch for realization of otherwise of or deal with all or any part of the said goods etc, as provided therein.

5) Name and Address and description of the person entitled to the charge.

Citi Bank NA

Bandra Kurla Complex, G-Block Bandra [East], Mumbai – 400051, Maharashtra, India

6) Date  and brief description of instrument modifying the charge

Deed of Modification dated 31.01.2004

Relating to enhancement of credit facilities

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

the original charge was created on 21.06.2001 for securing fund based facilities of Rs. 24.000 Millions and non fund based facilities of Rs. 2.500 Millions again hypothecation of stock and book debts.

 

The bank has now extended the facilities to the company and made a deed of modification to the extend of Rs. 31.500 Millions which is an increase of Rs. 5.000 Millions against the said stock and book debts hypothecated by way of first charge to the lender

 

Other terms and conditions will remain same as per original Goods Security Agrement. 

 

AS PER WEBSITE

 

World-Class Pharmaceutical Excipients And Services


Colorcon, Inc. is a global company that develops, manufactures and supplies specialty chemicals and excipients for the pharmaceutical industry. 


Their core business is the design and technical support of advanced coating systems for pharmaceutical dosage forms for immediate, sustained and enteric release. In addition, the company's technological capabilities include assistance in the development of solid dosage formulations.


In order to meet the diverse requirements of international customers, they have positioned their business offices, manufacturing facilities and technical service laboratories in strategic locations around the world. This global network ensures the fast, timely access to the products and services that customers demand today.


As an industry leader, Colorcon also makes a point of sharing its expertise through a variety of ongoing educational courses, seminars and symposiums. These efforts all support a common goal: To help their customers succeed in the highly competitive and increasingly global pharmaceutical market.


No-Tox® Products


Colorcon No-Tox Products is singularly devoted to the manufacture of products that meet the highest standards set by national regulatory agencies. They meet these standards because their products directly touch the lives of millions of people the world over.    Their non-toxic printing inks are employed for direct and indirect contact applications involving food, medical devices and associated packaging.

Food & Confectionery Products

Colorcon offers a wide variety of products to color, glaze, polish, coat and enhance the appearance of your products; everything you need to produce truly great confections and foods. Forms of colorants include dry color dispersions, dry pigments, pastes and liquids using FD&C certified lakes, dyes and natural colorants. Also available are sealants, barriers, polishes and glazes.

Their expertise in developing customer color formulations will help your product be easily recognized and memorable.

Partner Companies

Their affiliate company is:

Micron Technologies® - specialists in contract micronizing and milling services. Micron helps pharmaceutical manufacturers worldwide achieve greater product effectiveness through the application of particle size reduction technologies.

Colorcon provides a wide range of complete film-coatings systems, modified-release technologies, and excipients.  Their best-of-class products are complemented by their value-added services, including global technical assistance and regulatory information services, training seminars, and independent research support. 

As the preferred supplier of major pharmaceutical companies worldwide, their products feature some of the most advanced technology available in solid oral dose formulations. Major pharmaceutical and nutritional supplement developers rely on Colorcon to assist them in the development of cost-effective, high quality products with superior performance and appearance.

The Food & Confectionery Division of Colorcon offers a wide variety of products to color, glaze, polish, coat and enhance the appearance of your products; everything you need to produce truly great confections and foods.

Their best-of-class technologies are complemented by their value-added services, including technical service, global regulatory information and independent research support. With their expanding portfolio of advanced products and services, and an organization built to provide product development team support, they are dedicated to assuring their customers’ success from every point of view.

Press Releases

November 2001 - Panning Special Effects

New panned confectionery products on the market today rely on visual special effects to give their appearance a point of difference. Confectioners have several techniques at their disposal to decorate or change the appearance of traditional panned confections including the speckling, striping, blushing, engrossing, polishing and printing. 
   
Brand identity, achieved through these methods, is a process manageable in any facility if pan operators have an understanding of specific techniques and a familiarization of challenges commonly encountered. 

Pam Gesford, Technical Services Manager at Colorcon, discusses challenges for panned confections in a timely article appearing in Manufacturing Confectionery Magazine.

Colorcon is singularly devoted to the manufacture of products that meet the highest standards set by national regulatory agencies. They meet these standards because their products directly touch the lives of millions of people the world over.

Their non-toxic printing inks are employed for direct and indirect contact applications involving food, medical devices and associated packaging.

For Immediate Release

 

COLORCON INDIANAPOLIS PLANT IS ISO 9001:2000 CERTIFIED

The Indianapolis, IN manufacturing facility of Colorcon has been granted ISO 9001:2000 certification. This Internationally recognized standard for Quality Management provides a framework for a Quality System with focus on aspects such as Management Commitment, Document & Record Control, Change Control, Corrective & Preventative Action, Customer Satisfaction and Continuous Improvement. It applies not just to the manufacturing activities of an organization, but to all activities. Colorcon is committed to ensuring that all of its sites' Quality Management Systems are world class and will continue to keep getting better in their effort to become their customers' formulation partner of choice.

The Indianapolis, IN facility of Colorcon manufactures products such as the multifunctional core excipient Starch 1500 and the ethylcellulose dispersion Surelease, designed for sustained release and tastemasking applications.

Colorcon and Dow ANNOUNCE A GLOBAL CONTROLLED RELEASE ALLIANCE

Colorcon and The Dow Chemical Company have formed a global strategic alliance to better service their customers' controlled release formulation development.  As a result of this new collaboration, Colorcon will become the exclusive global representative of Dow Excipients with oral controlled release application. Product lines affected include select METHOCEL™ Hypromellose polymers, all premium or NF grade ETHOCEL™ Ethylcellulose polymers and all POLYOX™ Poly(ethylene oxide) resins used in pharmaceutical applications.

 

This collaboration places global marketing, sales, technical support and customer service for these products in Colorcon's hands. It complements Colorcon's Modified Release Technologies portfolio of fully-formulated products, applications data and global technical service and logistics infrastructure and enhances their ability to support their customers' oral solid dosage development efforts throughout the world.

Colorcon will begin the technical support of CR projects on the following effective dates:

Region             New CR Products         Effective Date

North America (incl. PR)           METHOCEL™ July 1, 2007

                        ETHOCEL™      July 1, 2007

                        POLYOX™        July 1, 2007

EMEA              ETHOCEL™      October 1, 2007

                        POLYOX™        October 1, 2007

Asia-Pacific (ex JP)                    POLYOX™       July 1, 2007

Latin America   POLYOX™        July 1, 2007

                                                

 

For Immediate Release

COLORCON ANNOUNCES THE OPENING OF NEW TECHNICAL SERVICE LABORATORY IN MONTREAL, QUEBEC, CANADA

West Point, Pennsylvania, USA, (date)— Effective September 1, 2006,

Colorcon proudly opens its 17th Technical Service Laboratory (TSL), the first in Canada, located in Montreal, Quebec. This fully equipped TSL is designed to assist local product technical teams expedite the development of their solid oral dosage forms.

The modern facility, now available for customer use will also serve as a Training Center hosting Coating Schools, Modified Release Forums, Formulation Development Seminars and more.

To contact a member of Colorcon's Technical Team in Montreal, please call:

 

Tel:  514-337-8341, Fax: 514-337-9159 or

                                                                          

For Immediate Release


ANNOUNCING THE AVAILABILITY OF A UNIQUE COLOR GUIDE FOR TABLET FORMULATORS

 

West Point, Pennsylvania, USA, 28 June 2006—Colorcon has created a unique, new reference tool for pharmaceutical formulators and their product development teams called the Colorcon Color Guide.  The easy-to-use Guide was designed to help development groups select colors for their film-coated tablets containing pigments with the highest probability of regulatory acceptance in global or regional target markets.

Included in the Guide is a summary of the different types of pigments - Lakes, synthetic iron oxides and natural colorants - commonly used in pharmaceutical film coating formulas. Color options are organized according to color family for easy reference.   

 

The new Guide was designed to accommodate updates and changes implemented by the global regulatory authorities through the use of  a Color Selector  which is a clear acetate overlay sheet.  These unique Selectors help pharmaceutical technical and brand development teams confidently and accurately narrow the selection of colors for the regions in which the dosage is to be marketed.  One Selector is provided to limit color choices appropriate for European Union Countries (EU) as well as for North America which includes the USA, Canada and Mexico.  A second Selector will define colors that can be used in the EU + North America as well as in Japan.  

Colorcon developed this Color Guide as part of its commitment to assist customers in making rapid and accurate color selections as part of the progression in launching a film coated, or enteric coated tablet. The options displayed in the Color Guide represent just a small sample of the colors available in fully formulated film coating systems. Compact and easy to store for ready reference, third Color Guide is backed by the support of the Colorcon technical and regulatory support staff.


For immediate release

COLORCON ANNOUNCES THE OPENING OF THREE DESIGN CENTERS DEVOTED TO TABLET BRAND IMAGING

 West Point, Pennsylvania, USA, (date)— Effective May 1, 2005, the first three Colorcon Global Tablet Design Centers™ (TDC™) will be open and ready for client use. These specially equipped, high-tech conference centers have been created to facilitate the research and design of distinctive pharmaceutical tablet dosage forms.   

Covering three continents, the first Tablet Design Centers to open are located in West Point, Pennsylvania, Dartford, Kent, England, and Goa, India. Sites for future TDC™ facilities include China and Japan, scheduled to open by year end. The facilities form an integral part of the BESTÒ Brand Enhancement System for Tablets, a unique service supporting new product development and brand management of an existing product. 

 

Each Design facility is equipped for efficient, effective on-site collaboration between Colorcon experts and a client’s own project team. Utilizing proprietary Colorcon software, a uniquely shaped and colored tablet can be designed and viewed dimensionally on screen, demonstrating how the final dosage form would look. Colorcon can also advise on unique trade dress options such as shade, gloss, pearlesence, and unique brand identification marks including printed or debossed logos.  This supports brand recognition and helps to combat the exposure to potential counterfeiting. Regulatory acceptability of the final coating selection is determined through Colorcon’s unique formulations database.  

 

One Colorcon customer, on visiting the new West Point Tablet Design Center, commented “We were able to accomplish in one day what previously would have required up to nine months.”  

 

Pharmaceutical manufacturers can bring their project teams to a Tablet Design Center and also collaborate via conference calls, saving travel time while ensuring clear, consistent communication regarding tablet design potential. Photorealistic images of the client’s dosage design are available throughout the process.                                                                  

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.66

UK Pound

1

Rs.81.70

Euro

1

Rs.55.05

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

85

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions